ASX:EVEFood, Beverage & TobaccoPackaged Foods & Meats
Eve Health Group Ltd
$0.022
Day Range
$0.022 – $0.023
52 Week Range
$0.017 – $0.038
Volume
28.75K
Avg Volume (10D)
177.09K
Market Cap
$7.75M
Price Chart
Market Statistics
Open$0.023
Previous Close$0.022
Day High$0.023
Day Low$0.022
52 Week High$0.038
52 Week Low$0.017
Valuation
Market Cap7.75M
Shares Outstanding352.33M
Price to Book1.74
Trading Activity
Volume28.75K
Value Traded645.07
Bid$0.022 × 25,000
Ask$0.023 × 116,843
Performance
1 Day0.00%
5 Day-8.00%
13 Week9.52%
52 Week-42.50%
YTD9.52%
Technical Indicators
RSI (14)37.48
50-Day SMA$0.026
200-Day SMA$0.026
Latest News
Biotechnology
EVE Health Appoints New CEO to Lead Company Through Next Phase of Growth
EVE Health appoints COO Ben Rohr as new CEO to drive next growth phase and accelerate commercialisation; Damian Wood shifts to regulatory/medical affairs.
Biotechnology
EVE Health Increases Capital Raising to $1.3m with $400,000 Cornerstone Investment
EVE Health Group lifts capital raise to $1.3m with $400k cornerstone, signalling reformulated-drug strategy and new science adviser amid Libbo launch.
Biotechnology
EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline
EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.
Biotechnology
EVE Health Advances Reformulated Drugs Targeting Sexual Health and Cardiovascular Markets
EVE Health advances reformulated ED/PE sprays and Apixaban delivery, expanding its sexual health and cardiovascular pipeline.